from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1786/-

LFCtreatmentdescriptionclass of inhibitor

0.403

Amikacinug/mL Amikacintranslation

2.035

Cap5-10ug/mL Capreomycintranslation

2.202

Rox10-50 ug/mL Roxithromycintranslation

-0.614

SM2-5 ug/mL Streptomycintranslation

1.436

Tet5-10 ug/mL Tetracyclinetranslation

0.469

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.466

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.344

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.232

Clofazimine10-13 ug/mL Clofaziminerespiration

0.192

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.206

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.033

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.799

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.607

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.622

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.812

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.567

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.106

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.597

KCN5-20 ug/mL Potassium cyaniderespiration

0.271

NaN30.2-2 mM Sodium aziderespiration

-0.144

Nigericin50 uM Nigericinrespiration

-0.503

TRC10-150 ug/mL Triclosanrespiration

-0.821

TRZ10-25 ug/mL Thioridazinerespiration

-0.131

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.105

menadione6-10 ug/mL Menadionerespiration

-0.143

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.160

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.266

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.988

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.286

NRP_1Non-replicating persistence stage 1dosRassociated

0.428

Amp0.2mg/mL AmpicillincellWall

-0.154

Cephalexin20-100 ug/mL CephalexincellWall

0.153

Cerulenin0.32-5 ug/mL CerulenincellWall

0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.052

EMB10-20 ug/mL EthambutolcellWall

-0.015

Eta12-40 ug/mL EthionamidecellWall

0.759

INH0.2-0.4 ug/mL IsoniazidcellWall

0.046

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.410

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.622

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.088

BZA0.12 mg/mL BenzamidearomaticAmides

-0.307

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.453

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.288

H2O24 mM hydrogen peroxideDNAdamaging

-0.028

Levo10 ug/mL LevofloxacinDNAdamaging

0.319

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.751

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.285

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.667

UVUV-irradiationDNAdamaging

-0.537

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.467

Antimycin12.5-50 ug/mL Antimycin A?

-0.234

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.259

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.653

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.018

PA8240.2-2 ug/mL PA-824?

-0.286

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.237

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.256

Verapamil50 uM Verapamil?

0.004

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.692

methoxatin10-20 ug/mL Methoxatin?